Pages that link to "Q34105851"

The following pages link to The chimeric protein tyrosine kinase ETV6-NTRK3 requires both Ras-Erk1/2 and PI3-kinase-Akt signaling for fibroblast transformation (Q34105851):

Displaying 32 items.

• New tricks from an old oncogene: gene fusion and copy number alterations of MYB in human cancer (Q24620308) (← links)
• TRKing down an old oncogene in a new era of targeted therapy (Q28254287) (← links)
• The ETV6-NTRK3 chimeric tyrosine kinase suppresses TGF-beta signaling by inactivating the TGF-beta type II receptor (Q34132159) (← links)
• Mutations in the SAM domain of the ETV6-NTRK3 chimeric tyrosine kinase block polymerization and transformation activity (Q34181347) (← links)
• ETV6-NTRK3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of AP1 complex (Q36328085) (← links)
• The splicing-factor oncoprotein SF2/ASF activates mTORC1. (Q36926966) (← links)
• Fusion genes in solid tumors: an emerging target for cancer diagnosis and treatment (Q37353937) (← links)
• Soft tissue sarcomas with non-EWS translocations: molecular genetic features and pathologic and clinical correlations (Q37461034) (← links)
• E-cadherin cell-cell adhesion in ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase (Q37531718) (← links)
• Secretory Breast Carcinoma: Unique, Triple-Negative Carcinoma With a Favorable Prognosis and Characteristic Molecular Expression (Q37963004) (← links)
• Targeting NTRK fusion in non-small cell lung cancer: rationale and clinical evidence (Q38819055) (← links)
• A Next-Generation TRK Kinase Inhibitor Overcomes Acquired Resistance to Prior TRK Kinase Inhibition in Patients with TRK Fusion-Positive Solid Tumors (Q40173988) (← links)
• BRCA2, EGFR, and NTRK mutations in mismatch repair-deficient colorectal cancers with MSH2 or MLH1 mutations (Q41093124) (← links)
• Chaperones as thermodynamic sensors of drug-target interactions reveal kinase inhibitor specificities in living cells (Q41813875) (← links)
• Mutation of the salt bridge-forming residues in the ETV6-SAM domain interface blocks ETV6-NTRK3-induced cellular transformation (Q42149962) (← links)
• Genomic profiling of breast secretory carcinomas reveals distinct genetics from other breast cancers and similarity to mammary analog secretory carcinomas. (Q42510239) (← links)
• NTRK3 kinase fusions in Spitz tumours (Q42709455) (← links)
• The insulin-like growth factor I receptor is required for Akt activation and suppression of anoikis in cells transformed by the ETV6-NTRK3 chimeric tyrosine kinase. (Q43241596) (← links)
• Recurrent and metastatic congenital mesoblastic nephroma: where does the evidence stand? (Q48151927) (← links)
• Novel identification of STAT1 as a crucial mediator of ETV6-NTRK3-induced tumorigenesis (Q49388791) (← links)
• Identification of NTRK3 Fusions in Childhood Melanocytic Neoplasms (Q51040335) (← links)
• Platelet-derived growth factor mediates interleukin-13-induced collagen I production in mouse airway fibroblasts (Q51704419) (← links)
• The crucial role of multiomic approach in cancer research and clinically relevant outcomes. (Q52363678) (← links)
• A new ETV6-NTRK3 cell line model reveals MALAT1 as a novel therapeutic target - a short report. (Q52800255) (← links)
• Signaling by NTRK3 (TRKC) (Q56861007) (← links)
• Activated NTRK3 signals through PI3K (Q56861011) (← links)
• Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical Application (Q57154788) (← links)
• Antitumor activity of larotrectinib in tumors harboring gene fusions: a short review on the current evidence (Q64079974) (← links)
• Anaplastic lymphoma kinase-negative uterine inflammatory myofibroblastic tumor containing the ETV6-NTRK3 fusion gene: a case report (Q89098699) (← links)
• Insulin-like growth factor 1 receptor stabilizes the ETV6-NTRK3 chimeric oncoprotein by blocking its KPC1/Rnf123-mediated proteasomal degradation (Q89108056) (← links)
• Revisiting NTRKs as an emerging oncogene in hematological malignancies (Q90262410) (← links)
• Roles of TrkC Signaling in the Regulation of Tumorigenicity and Metastasis of Cancer (Q92633091) (← links)